Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about James Lanthier
Recent news which mentions James Lanthier
Next-Generation Psychedelics Shows Promise With Upcoming Clinical Trials
October 07, 2022
Tickers
MSSTF
Tags
Markets
Next/Generation
USPTO
From
Benzinga
Cybin Acquires Exclusive License To Mindset Pharma's Tryptamine Compounds Family
September 27, 2022
Tickers
CYBN
MSSTF
Tags
Psychedelics
James Lanthier
CYBN
From
Benzinga
Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close?
September 14, 2022
Tickers
MSSTF
Tags
major depressive disorder
Global
Legal
From
Benzinga
Psychedelics Companies Explore & Protect Their Findings, This Firm Is Doing That In 16 Countries
September 07, 2022
Tickers
MSSTF
Tags
Second/Generation Psychedelics
James Lanthier
MSP/1014
From
Benzinga
This Company Just Created 3 Brand New Psychedelics—Without The Hallucinogenic Side Effects
August 31, 2022
Tickers
MSSTF
Tags
Markets
Global
Management
From
Benzinga
Intranasal Psychedelics Platform Is Here, Check Out Mindset's New Development
June 30, 2022
Tickers
MSSTF
Tags
Cannabis
Benzinga
Penny Stocks
From
Benzinga
Mindset Partners With Canadian Psychiatric Research Hospital For Preclinical Study Of Psilocybin-Derived MSP-1014
June 22, 2022
Tickers
MSSTF
Tags
Cannabis
Benzinga
Biotech
From
Benzinga
Mindset Approved For Patent Application Involving Psilocin Derivatives For Central Nervous System Disorders
June 10, 2022
Tickers
MSSTF
Tags
Psychedelics
Market News
the United States Patent and Trademark Office
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.